Valneva SE (VALN) FCF Margin (QoQ) (2021 - 2026)
Valneva SE (VALN) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,896.00 |
| Dec 31, 2025 | -1,920.00 |
| Sep 30, 2025 | -6,714.00 |
| Jun 30, 2025 | 1,004.00 |
| Mar 31, 2025 | 1,844.00 |
| Dec 31, 2024 | -2,140.00 |
| Sep 30, 2024 | 8,795.00 |
| Jun 30, 2024 | -2,518.00 |
| Mar 31, 2024 | 14,071.00 |
| Dec 31, 2023 | -15.12 Mn |
| Sep 30, 2023 | 29.42 Mn |
| Jun 30, 2023 | -14.31 Mn |
| Mar 31, 2023 | 3,769.00 |
| Dec 31, 2022 | -4,486.00 |
| Sep 30, 2022 | 3,980.00 |
| Jun 30, 2022 | -1,251.00 |
| Mar 31, 2022 | -3,655.00 |
| Dec 31, 2021 | 3,574.00 |
| Sep 30, 2021 | -32,431.00 |
| Jun 30, 2021 | -3,563.00 |